Patrick Hranitzky to Incidence
This is a "connection" page, showing publications Patrick Hranitzky has written about Incidence.
Connection Strength
0.098
-
Gianni C, Mohanty S, Di Biase L, Metz T, Trivedi C, Gökoglan Y, Günes MF, Bai R, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Horton RP, Hranitzky PM, Sanchez JE, Halbfaß P, Müller P, Schade A, Deneke T, Tomassoni GF, Natale A. Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation. Heart Rhythm. 2016 Apr; 13(4):830-5.
Score: 0.023
-
Mohanty S, Mohanty P, Trivedi C, Gianni C, Bai R, Burkhardt JD, Gallinghouse JG, Horton R, Sanchez JE, Hranitzky PM, Al-Ahmad A, Bailey S, Di Biase L, Natale A. Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction. Heart Rhythm. 2015 Sep; 12(9):1963-71.
Score: 0.023
-
Mohanty S, Natale A, Mohanty P, DI Biase L, Trivedi C, Santangeli P, Bai R, Burkhardt JD, Gallinghouse GJ, Horton R, Sanchez JE, Hranitzky PM, Al-Ahmad A, Hao S, Hongo R, Beheiry S, Pelargonio G, Forleo G, Rossillo A, Themistoclakis S, Casella M, Russo AD, Tondo C, Dixit S. Pulmonary Vein Isolation to Reduce Future Risk of Atrial Fibrillation in Patients Undergoing Typical Flutter Ablation: Results from a Randomized Pilot Study (REDUCE AF). J Cardiovasc Electrophysiol. 2015 Aug; 26(8):819-825.
Score: 0.023
-
Singh JP, Rosenthal LS, Hranitzky PM, Berg KC, Mullin CM, Thackeray L, Kaplan A. Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace. 2009 Dec; 11(12):1647-53.
Score: 0.015
-
Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Am J Cardiol. 2008 Dec 01; 102(11):1427-32.
Score: 0.014